Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.

@article{Zhao2005LateCA,
  title={Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.},
  author={K. Zhao and Xue-hui Shi and G. Jiang and W. Yao and Xiaomao Guo and G. Wu and Longyu Zhu},
  journal={International journal of radiation oncology, biology, physics},
  year={2005},
  volume={62 4},
  pages={
          1014-20
        }
}
PURPOSE Late course accelerated hyperfractionated (LCAF) radiotherapy (RT) is as effective as standard chemoradiotherapy for nonsurgical management of locally advanced esophageal squamous cell carcinoma (SCC). We have evaluated further the efficacy of concurrent LCAF RT and chemotherapy. METHODS AND MATERIALS In all, 111 eligible patients with esophageal SCC were randomized to receive LCAF alone (LCAF) or concurrent LCAF and chemotherapy (LCAT+CT) between March 1998 and July 2000. All… Expand
Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma.
  • Bao-sheng Li, H. Gong, +5 authors J-M Yu
  • Medicine
  • Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
  • 2011
Clinical Study on Lobaplatin Combined with 5-Fu and Concurrent Radiotherapy in Treating Patients with Inoperable Esophageal Cancer.
Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Late course accelerated fractionation in radiotherapy of esophageal carcinoma.
  • X. Shi, W. Yao, T. Liu
  • Medicine
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 1999
Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy.
  • D. Adelstein, T. Rice, +7 authors G. Zuccaro
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.
  • M. al-Sarraf, K. Martz, +7 authors B. Emami
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1997
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
  • B. Minsky, T. Pajak, +6 authors D. Kelsen
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002
Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.
...
1
2
3
...